Debt-to-equity in % of Ventyx Biosciences, Inc. from Q2 2022 to Q3 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ventyx Biosciences, Inc. quarterly Debt-to-equity history and change rate from Q2 2022 to Q3 2025.
  • Ventyx Biosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 10%, a 2.74% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Ventyx Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 10% 0% -2.7% 30 Sep 2025
Q2 2025 9% -2% -20% 30 Jun 2025
Q1 2025 9% -1% -10% 31 Mar 2025
Q4 2024 9% 0% -2.4% 31 Dec 2024
Q3 2024 10% +3% +40% 30 Sep 2024
Q2 2024 11% +5% +74% 30 Jun 2024
Q1 2024 10% +3% +51% 31 Mar 2024
Q4 2023 9% +2% +21% 31 Dec 2023
Q3 2023 7% 0% -5.9% 30 Sep 2023
Q2 2023 6% -2% -28% 30 Jun 2023
Q1 2023 7% 31 Mar 2023
Q4 2022 7% 31 Dec 2022
Q3 2022 7% 30 Sep 2022
Q2 2022 9% 30 Jun 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.